These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2959203)

  • 21. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Estrogen antagonists and inhibitors in hormone therapy of breast cancer].
    Dryzhak VI
    Vopr Onkol; 1989; 35(7):771-8. PubMed ID: 2528239
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prolactin and cancer of the breast. II. Prediction of the response to hormone treatment. The Minton test].
    Cueto Ladrón de Guevara J; García Puche JL; Pedraza V
    Rev Esp Oncol; 1985; 32(3):459-70. PubMed ID: 3870537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E; Jouve M; Palangie T; Bretaudeau B; Asselain B; Magdelenat H; Merle S; Zajdela A; Pouillart P
    Bull Cancer; 1984; 71(1):22-9. PubMed ID: 6324934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New developments in hormonal therapy for breast cancer].
    Tominaga T
    Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
    Blossey HC; Wander HE; Nagel GA; Köbberling J; Kleeberg U
    Onkologie; 1982 Aug; 5 Suppl():34-41. PubMed ID: 6290955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal trends in the use of adjuvant systemic therapy in breast cancer: a population based study in Sweden 1976-2005.
    Kemetli L; Rutqvist LE; Jonsson H; Nyström L; Lenner P; Törnberg S
    Acta Oncol; 2009; 48(1):59-66. PubMed ID: 18752084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of GnRH analogues in early and advanced breast carcinomas].
    Ségura C; Avenin D; Gligorov J; Selle F; Estéso A; Beerblock K; Emile G; Do Huyen N; Lotz JP
    Gynecol Obstet Fertil; 2005 Nov; 33(11):914-9. PubMed ID: 16246613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Internal endocrine therapy of breast cancer].
    Yoshida M; Miura S
    Gan To Kagaku Ryoho; 1984 May; 11(5):989-98. PubMed ID: 6372698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
    Petru E; Schmähl D
    Klin Wochenschr; 1987 Oct; 65(20):959-66. PubMed ID: 2963170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer (non-metastatic).
    Dixon JM; Rodger A; Stebbing J
    Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hormone treatment of metastasizing breast carcinoma].
    Navarra S; Melita P; Di Mauro S; Calbo L; Belnome N
    Minerva Chir; 1981 Jun; 36(12):853-60. PubMed ID: 6454856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
    Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
    J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy].
    Tominaga T
    Gan No Rinsho; 1983 May; 29(6):628-31. PubMed ID: 6308307
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of breast cancer in aged women].
    Berta V; Perelli-Ercolini M; Beani G
    Chir Ital; 1980 Dec; 32(6):1543-51. PubMed ID: 6894717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study.
    Hughes LL; Gray RJ; Solin LJ; Robert NJ; Martino S; Tripathy D; Ingle JN; Wood WC; ; ; ;
    Cancer; 2004 Sep; 101(5):969-72. PubMed ID: 15329905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hormonal control of disseminated breast cancer].
    Voznyĭ EK; Meshcheriakova NG; Biakhov MIu; Vasiuta NIu
    Sov Med; 1990; (6):94-7. PubMed ID: 2144368
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.